256 related articles for article (PubMed ID: 33186543)
21. Congenital dyserythropoietic anemia type III. studies on erythroid differentiation of blood erythroid progenitor cells (BFUE) in vitro.
Vainchenker W; Breton-Gorius J; Guichard J; Bouguet J; Henri A; Rochant H; Goudsmit R
Exp Hematol; 1980 Sep; 8(8):1057-62. PubMed ID: 7202587
[TBL] [Abstract][Full Text] [Related]
22. Dynamic subunit turnover in ESCRT-III assemblies is regulated by Vps4 to mediate membrane remodelling during cytokinesis.
Mierzwa BE; Chiaruttini N; Redondo-Morata L; von Filseck JM; König J; Larios J; Poser I; Müller-Reichert T; Scheuring S; Roux A; Gerlich DW
Nat Cell Biol; 2017 Jul; 19(7):787-798. PubMed ID: 28604678
[TBL] [Abstract][Full Text] [Related]
23. Type I dyserythropoietic anemia. A 30-year follow-up.
Maeda K; Saeed SM; Rebuck JW; Monto RW
Am J Clin Pathol; 1980 Mar; 73(3):433-8. PubMed ID: 7361726
[TBL] [Abstract][Full Text] [Related]
24. Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.
Sharma P; Das R; Bansal D; Trehan A
Hematology; 2015 Mar; 20(2):104-7. PubMed ID: 24801240
[TBL] [Abstract][Full Text] [Related]
25. KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.
Kohara H; Utsugisawa T; Sakamoto C; Hirose L; Ogawa Y; Ogura H; Sugawara A; Liao J; Aoki T; Iwasaki T; Asai T; Doisaki S; Okuno Y; Muramatsu H; Abe T; Kurita R; Miyamoto S; Sakuma T; Shiba M; Yamamoto T; Ohga S; Yoshida K; Ogawa S; Ito E; Kojima S; Kanno H; Tani K
Exp Hematol; 2019 May; 73():25-37.e8. PubMed ID: 30876823
[TBL] [Abstract][Full Text] [Related]
26. The regulation of Endosomal Sorting Complex Required for Transport and accessory proteins in multivesicular body sorting and enveloped viral budding - An overview.
Ahmed I; Akram Z; Iqbal HMN; Munn AL
Int J Biol Macromol; 2019 Apr; 127():1-11. PubMed ID: 30615963
[TBL] [Abstract][Full Text] [Related]
27. ESCRT and Membrane Protein Ubiquitination.
Migliano SM; Teis D
Prog Mol Subcell Biol; 2018; 57():107-135. PubMed ID: 30097773
[TBL] [Abstract][Full Text] [Related]
28. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1{alpha} localization in erythroblasts.
Renella R; Roberts NA; Brown JM; De Gobbi M; Bird LE; Hassanali T; Sharpe JA; Sloane-Stanley J; Ferguson DJ; Cordell J; Buckle VJ; Higgs DR; Wood WG
Blood; 2011 Jun; 117(25):6928-38. PubMed ID: 21364188
[TBL] [Abstract][Full Text] [Related]
29. [Congenital dyserythropoietic anemia type II: a case report and literature review].
Li Y; Zhao X; Zhou K; Li Y; Li JP; Ye L; Peng GX; Fan HH; Jing LP; Zhang L; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):270-3. PubMed ID: 22781715
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural features in two cases of congenital dyserythropoietic anemia type II.
Moldoveanu E; Coliţă A; Hălălău F
Rom J Morphol Embryol; 1994; 40(3-4):133-6. PubMed ID: 7548885
[TBL] [Abstract][Full Text] [Related]
31. Ineffective erythropoiesis underlies the clinical heterogeneity of congenital dyserythropoietic anemia type II (CDA II).
Kostaridou S; Polychronopoulou S; Premetis E; Papassotiriou I; Stamoulakatou A; Haidas S
Pediatr Int; 2004 Jun; 46(3):274-9. PubMed ID: 15151542
[TBL] [Abstract][Full Text] [Related]
32. A new case of congenital dyserythropoietic anaemia, type III: studies of the cell cycle distribution and ultrastructure of erythroblasts and of nucleic acid synthesis in marrow cells.
Wickramasinghe SN; Parry TE; Williams C; Bond AN; Hughes M; Crook S
J Clin Pathol; 1982 Oct; 35(10):1103-9. PubMed ID: 6182166
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C Virus-Induced ROS/JNK Signaling Pathway Activates the E3 Ubiquitin Ligase Itch to Promote the Release of HCV Particles via Polyubiquitylation of VPS4A.
Deng L; Liang Y; Ariffianto A; Matsui C; Abe T; Muramatsu M; Wakita T; Maki M; Shibata H; Shoji I
J Virol; 2022 Mar; 96(6):e0181121. PubMed ID: 35044214
[TBL] [Abstract][Full Text] [Related]
34. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
[TBL] [Abstract][Full Text] [Related]
35. Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.
Hamada M; Doisaki S; Okuno Y; Muramatsu H; Hama A; Kawashima N; Narita A; Nishio N; Yoshida K; Kanno H; Manabe A; Taga T; Takahashi Y; Miyano S; Ogawa S; Kojima S
Int J Hematol; 2018 Sep; 108(3):306-311. PubMed ID: 29936674
[TBL] [Abstract][Full Text] [Related]
36. Transmission and scanning electron microscopy study on congenital dyserythropoietic anemia type I.
Conde E; Mazo E; Baro J; Lafarga M; Cuadrado MA; Recio M; Zubizarreta A
Acta Haematol; 1983; 70(4):243-9. PubMed ID: 6414210
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].
Rössler J; Havers W
Klin Padiatr; 2000; 212(4):153-8. PubMed ID: 10994542
[TBL] [Abstract][Full Text] [Related]
38. Congenital dyserythropoietic anemia type I: report of a pair of siblings in Japan.
Kuribayashi T; Uchida S; Kuroume T; Umegae S; Omine M; Maekawa T
Blut; 1979 Sep; 39(3):201-9. PubMed ID: 476312
[TBL] [Abstract][Full Text] [Related]
39. Ablation of
Kumari R; Grzywa TM; Małecka-Giełdowska M; Tyszkowska K; Wrzesień R; Ciepiela O; Nowis D; Kaźmierczak P
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563652
[TBL] [Abstract][Full Text] [Related]
40. Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer.
Szymańska E; Nowak P; Kolmus K; Cybulska M; Goryca K; Derezińska-Wołek E; Szumera-Ciećkiewicz A; Brewińska-Olchowik M; Grochowska A; Piwocka K; Prochorec-Sobieszek M; Mikula M; Miączyńska M
EMBO Mol Med; 2020 Feb; 12(2):e10812. PubMed ID: 31930723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
